EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

A Systematic Review and Meta-Analysis of Mirnas for the Detection of Cervical Cancer

Christopher Rt Hillyar iD, Shivani S Kanabar, Kamil R Pufal, Joshua Li Saw Hee, Alexander W Lawson, Yethrib Mohamed, Duha Jasim, Lara Reed, Kathrine S Rallis iD, Anjan Nibber

Epigenomics · 2023

DOI: 10.2217/epi-2023-0183 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Epigenomics, 2023. Verfasst von Christopher Rt Hillyar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Green Templeton College, University of Oxford, Oxford, OX2 6HG, UK. Hauptthemen laut MEDLINE: MicroRNAs, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 107 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to critically appraise the evidence of the diagnostic effectiveness of miRNAs for the detection of cervical cancer. Methods & materials: A systematic review and meta-analysis was performed, searching PubMed, EMBASE and Web of Science. An umbrella meta-analysis of meta-analyses of individual biomarkers was performed. A Grading of Recommendations, Assessment, Development and Evaluations (GRADE) assessment of evidence was also performed.

Results

A total of 52 miRNAs were included. Umbrella meta-analysis revealed significant heterogeneity in terms of sensitivity, specificity, receiver operating characteristic (ROC), positive predictive value and/or negative predictive value. Umbrella effects were 0.76 (95% CI: 0.73-0.78), 0.78 (95% CI: 0.75-0.81), 0.77 (95% CI: 0.75-0.80), 0.75 (95% CI: 0.71-0.79) and 0.76 (95% CI: 0.74-0.79), respectively.

Conclusion

Moderate quality evidence suggested miR199a-5p, miR21-5p and miR-141a had excellent diagnostic performance. miRNAs are small chemical messengers that play a role in the regulation of protein produced inside the cytoplasm of cells, including cancer cells. In cervical cancer cells, miRNAs become dysregulated – that is, their levels become increased or decreased – and therefore detecting their relative abundance or absence in test samples may enable identification of cervical cancer. This study aimed to systematically collect and appraise the evidence for the diagnostic ability of miRNAs for detection of cervical cancer. A systematic appraisal of the evidence was conducted by searching three research databases (PubMed, EMBASE and Web of Science) to collect evidence published up to 13 November 2022. Results for diagnostic performance of 52 miRNAs were extracted from 20 relevant studies. An assessment of risk of bias for each study was performed using a standardized checklist, which identified one high-quality study, 18 moderate-quality studies and one low-quality study. Results for each individual biomarker were assessed by meta-analytic methods, which generated weighted averages for 38 of 52 miRNAs. All 52 miRNAs were then compared using an umbrella meta-analysis (a weighted average of all miRNA biomarkers), which identified significant differences in diagnostic ability between miRNAs. Sensitivity analyses suggested that these differences were partly explained by differences in grades of cervical cancer and differences in types of sample used for testing. A GRADE assessment of the overall evidence quality suggested that moderate-quality evidence supported further investigation of three miRNA biomarkers (miR-199a-5p, miR-21-5p and miR-141a), which performed excellently (i.e., better than the umbrella weighted average) across five performance parameters, including sensitivity, specificity, receiver operator characteristic, positive predictive value and negative predictive value. In summary, this study suggested miR-199a-5p, miR-21-5p and miR-141a had excellent diagnostic performance for detection of cervical cancer and recommends further investigation of these miRNAs in randomized controlled trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsUterine Cervical NeoplasmsFemaleHumansBiomarkersROC CurveBiomarkers, Tumor

Stichwörter der Autor:innen

ROCbiomarkercervical cancercervical intraepithelial neoplasiameta-analysismiRNA sensitivitynegative predictive valuepositive predictive valuespecificity

Substanzen

MicroRNAsBiomarkersBiomarkers, Tumor

Autor:innen und Institutionen

  • Green Templeton College, University of Oxford, Oxford, OX2 6HG, UK.
  • Elderly Care, Royal Berkshire Hospital NHS Foundation Trust, Reading, RG1 5AN, UK.
  • General Surgery, Sandwell General Hospital, Sandwell & West Birmingham NHS Trust, West Bromwich, B71 4HJ, UK.
  • General Surgery, Queens Hospital Burton, University Hospitals of Derby and Burton NHS Trust, Burton-on-Trent, DE13 0RB, UK.
  • Renal Unit, New Cross Hospital, The Royal Wolverhampton NHS Trust, Wolverhampton, WV10 0QP, UK.
  • General Surgery, New Cross Hospital, The Royal Wolverhampton NHS Trust, Wolverhampton, WV10 0QP, UK.

ORCID-Profile: Christopher Rt Hillyar, Kathrine S Rallis

Zitieren

APA

Hillyar, C. R., Kanabar, S. S., Pufal, K. R., Saw Hee, J. L., Lawson, A. W., Mohamed, Y., Jasim, D., Reed, L., Rallis, K. S., & Nibber, A. (2023). A Systematic Review and Meta-Analysis of Mirnas for the Detection of Cervical Cancer. Epigenomics. https://doi.org/10.2217/epi-2023-0183

Vancouver

Hillyar CR, Kanabar SS, Pufal KR, Saw Hee JL, Lawson AW, Mohamed Y, et al. A Systematic Review and Meta-Analysis of Mirnas for the Detection of Cervical Cancer. Epigenomics. 2023. doi:10.2217/epi-2023-0183

BibTeX
@article{Hillyar2023,
  author = {Hillyar, Christopher Rt and Kanabar, Shivani S and Pufal, Kamil R and Saw Hee, Joshua Li and Lawson, Alexander W and Mohamed, Yethrib and Jasim, Duha and Reed, Lara and Rallis, Kathrine S and Nibber, Anjan},
  title = {A Systematic Review and Meta-Analysis of Mirnas for the Detection of Cervical Cancer},
  journal = {Epigenomics},
  year = {2023},
  doi = {10.2217/epi-2023-0183}
}
Kostenlos starten →